Acquiring Company
Supernus Pharmaceuticals
Acquired Company
Indivior Pharmaceuticals
RockvilleBiotechnologyHealth CareTherapeuticsBiopharmaBiotechnologyHealth CareMedicalPharmaceuticalDescription
Supernus Pharmaceuticals has announced its merger with Indivior Pharmaceuticals, aiming for a combined revenue of $2.2 billion. The deal is expected to streamline operations and align both companies' product portfolios in addiction treatment and central nervous system therapies. The merger will position the new entity for enhanced market presence and operational efficiencies.
Don't miss Supernus Pharmaceuticals's next move
Get an email the moment Supernus Pharmaceuticals makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Indivior Pharmaceuticals?
Indivior Pharmaceuticals was acquired by Supernus Pharmaceuticals, based in Rockville. The deal was reported on August 20, 2026. Supernus Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Supernus Pharmaceuticals is publicly traded (SUPN) and operates in Biotechnology.
When did Supernus Pharmaceuticals acquire Indivior Pharmaceuticals?
Supernus Pharmaceuticals's acquisition of Indivior Pharmaceuticals was reported on August 20, 2026. Supernus Pharmaceuticals has announced its merger with Indivior Pharmaceuticals, aiming for a combined revenue of $2.2 billion. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Indivior Pharmaceuticals do?
Indivior Pharmaceuticals, Inc. specializes in the treatment of addiction and is engaged in developing medicines to help individuals with substance use disorders. It is publicly traded (INDV), operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.